Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity

Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 4, 2008, Pages 236-242

  Kamal, Mohamed A ^a   Keep, Richard F ^a   Smith, David E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

5 aminolevulinic acid; Cefadroxil; Disposition; Dynamics; Glycylsarcosine; Knockout mice; PEPT2; Toxicity

Indexed keywords

AMINOLEVULINIC ACID; CEFADROXIL; GLYCYLSARCOSINE; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; COTRANSPORTER; DIPEPTIDE; HYDROGEN COUPLED OLIGOPEPTIDE TRANSPORTER PEPT2; HYDROGEN-COUPLED OLIGOPEPTIDE TRANSPORTER PEPT2;

AREA UNDER THE CURVE; CHOROID PLEXUS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXPOSURE; DRUG MEGADOSE; DRUG PENETRATION; DRUG TRANSPORT; GENETIC POLYMORPHISM; HEPATIC PORPHYRIA; HUMAN; LEAD POISONING; MENINGITIS; NEUROTOXICITY; NONHUMAN; PHARMACODYNAMICS; PHARMACOGENOMICS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; ANIMAL; GENETICS; PHYSIOLOGY;

AMINOLEVULINIC ACID; ANIMALS; CEFADROXIL; DIPEPTIDES; HUMANS; SYMPORTERS;

EID: 56149103172     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.23.236     Document Type: Review

References (44)

1. Daniel, H. and Kottra, G.: The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch., 447: 610-618 (2004).
2. Herrera-Ruiz, D. and Knipp, G. T.: Current perspectives on established and putative mammalian oligopeptide transporters. J. Pharm. Sci., 92: 691-714 (2002).
3. Fei, Y., Kanai, Y., Boron, W. F. and Heidiger, M. A.: Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature (Lond), 368: 563-566 (1994).
4. Lui, W., Liang, R., Ganapathy, V. and Leibach, F. H.: Molecular cloning of PEPT2, a new member of the H+/peptide cotransporter family from human kidney. Biochem. Biophys. Acta., 1235: 461-466 (1995).
5. Yamashita, T., Shimada, S., Tagaki, T. and Tohyama, M.: Cloning and functional expression of a brain peptide/histidine transporter. J Biol. Chem., 272: 10205-10211 (1997).
6. Sakata, K., Yamashita, T., Maeda, M. and Shimada, S.: Cloning of a lymphatic peptide/histidine transporter. J. Biochem., 356: 53-60 (2001).
7. Botka, C., Wittig, T., Graul, R., Nielson, C., Amidon, G. and Sadée, W.: Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics. AAPS Pharm. Sci., 2: 1-22 (2000).
8. Rubio-Aliaga, I. and Daniel, H.: Mammalian peptide transporters as targets for drug delivery. Trends pharmac. Sci., 23: 434-440 (2002).
9. Ogihara, H., Saito, H., Shin, B. C., Terado, T., Takenoshita, S., Nagamachi, Y., Inui, K. and Takata, K.: Immunolocalization of H+/peptide cotransporter in rat digestive tract. Biochem. Biophys. Res. Commun., 220: 848-852 (1996).
10. Groneberg, D. A., Döring, F., Eynott, P. R., Fischer, A. and Daniel, H.: Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am. J. Physiol. Gastrointest. Liver Physiol., 281: G697-G704 (2001).
11. Shen, H., Smith, D. E., Yang, T. and Brosius, F.: Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am. J. Physiol., 276: F658-F665 (1999).
12. +/peptide cotransporter. J. Biol. Chem., 270: 6456-6463 (1995).
13. Boll, M., Herget, M., Wagener, M., Weber, W. M., Markovich, D., Biber, J., Clauss, W., Murer, H. and Daniel, H.: Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. Proc. Natl. Acad. Sci. USA, 93: 284-289 (1996).
14. Döring, F., Walter, J., Will, J., Focking, M., Boll, M., Amasheh, S., Clauss, W. and Daniel, H.: Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin. Invest., 101: 2761-2767 (1998).
15. Berger, U. and Hediger, M.: Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat. Embryol., 199: 439-449 (1999).
16. Shen, H., Smith, D. E., Keep, R. F. and Brosius, F. C.: Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol. Pharm., 1: 248-256 (2004).
17. Novotny, A., Xiang, J., Stummer, W., Teuscher, N. S., Smith, D. E. and Keep, R.: Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J. Neurochem., 75: 321-328 (2000).
18. Shu, C., Shen, H., Keep, R. F. and Smith, D. E.: Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebral fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J. Pharmacol. Exp. Ther., 301: 820-829 (2002).
19. Teuscher, N. S., Novotny, A., Keep R. F. and Smith, D. E.: Functional evidence for the presence of PEPT2 in rat choroid plexus: Studies with glycylsarcosine. J. Pharmacol. Exp. Ther., 294: 494-499 (2000).
20. Teuscher, N. S., Keep, R. F. and Smith, D. E.: PEPT2-mediated uptake of neuropeptides in rat choroid plexus. Pharm. Res., 18: 807-813 (2001).
21. Groneberg, D. A., Döring, F., Nickolaus, M., Daniel, H. and Fischer, A.: Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia. Neurosci. Lett., 304: 181-184 (2001).
22. Groneberg, D. A., Nickolaus, M., Springer, J., Döring, F., Daniel, H. and Fischer, A.: Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am. J. Pathol., 158: 707-714 (2001).
23. Ocheltree, M., Shen, H., Hu, Y., Keep, R. F. and Smith, D. E.: Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J. Pharmacol. Exp. Ther., 35: 240-247 (2005).
24. Shen, H., Ocheltree, S., Hu, Y., Keep, R. F. and Smith, D. E.: Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab. Dispos., 35: 1209-1216 (2007).
25. Smith, D. E., Johanson, C. E. and Keep, R. F.: Peptide and peptide analog transport systems at the blood-CSF barrier. Adv. Drug Deliv. Rev., 56: 1765-1791 (2004).
26. Ocheltree, M., Keep, R. F., Shen, H., Yang, D., Hughes, B. and Smith, D. E.: Preliminary investigation into the expression of proton-coupled oligopeptide transporters in neural retina and retinal pigment epithelium (RPE): lack of functional activity in RPE plasma membranes. Pharm. Res., 20: 1364-1372 (2003).
27. Hu, Y., Shen, H., Keep, R. F. and Smith, D. E.: Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J. Neurochem., 103: 2058-2065 (2007).
28. Shen H, Smith D, Keep R, Xiang J, Brosius III FC.: Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in the choroid plexus. J. Biol. Chem., 278: 4786-4791 (2003).
29. Courtieu, L. and Drugeon, H.: Compared sensitivities of 532 bacterial strains to six cephalosporins. Int. J. Clin. Pharmacol. Res., 3: 195-201 (1983).
30. Anderson, E., Sassa, A., Bishop, F. and Desnick, J.: Disorders of heme biosynthesis: X-linked siderolblastic anemia and the porphyrias, in The Metabolic & Molecular Bases of Inherited Disease (Scriver, R., Beaudet, L., Sly, S. and Valle, D.), pp 2991-3062. McGraw-Hill, New York (2001).
31. Lindberg, P., Martini, R., Baumgartner, M., Erne, B., Borg, J., Zielasek, J., Ricker, K., Steck, A., Toyka, K.V. and Meyer U. A.: Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria. J. Clin. Invest., 103: 1127-1134 (1999).
32. Albers, W. and Fink, K.: Porphyric neuropathy. Muscle Nerve, 30: 410-422 (2004).
33. Klassen, D.: Heavy metals and heavy-metal antagonists, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton, L., Lazo, S. and Parker, L., eds), pp 1753-1775. McGraw-Hill, New York (2006).
34. Ocheltree, M., Shen, H., Hu, Y., Xiang, J., Keep, R. F. and Smith, D. E.: Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice. Pharm. Res., 21: 1680-1685 (2004).
35. Adhikari, A., Penatti, C. A., Resende, R., Ulrich, H., Britto, G. and Bechara, H.: 5-Aminolevulinate and 4,5-diox-ovalerate ions decrease GABAA receptor density in neuronal cells, synaptosomes and rat brain. Brain Res., 1093: 95-104 (2006).
36. Zhang, E., Emerick, R., Pak, Y., Wrighton, S. and Hillgren, K.: Comparison of human and monkey peptide transporters: PEPT1 and PEPT2. Mol. Pharm, 1: 201-210 (2004).
37. Fei, J., Ganapathy, V. and Leibach, F.: Molecular and structural features of the proton-coupled oligopeptide transporter superfamily. Prog. Nucleic Acid Res. Mol. Biol., 58: 239-261 (1998).
38. Ganapathy, M., Brandsch, M., Prasad, P., Ganapathy, V. and Leibach, F.: Differential recognition of b-lactam antibiotics by intestinal and renal peptide transporters, PEPT1 and PEPT2. J. Biol. Chem., 270: 25672-25677 (1995).
39. Biegel, A., Knutter, I., Hartrodt, B., Gabauer, S., Theis, S., Luckner, P., Kottra, G., Rastetter, M., Zebisch, K., Thondorf, I., Daniel, H., Neubert, K. and Brandsch, M.: The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids, 31: 137-156 (2006).
40. Sugawara, M., Huang, W., Fei, Y., Leibach, F., Ganapathy, V. and Ganapathy, M.: Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J. Pharm. Sci., 89: 781-789 (2000).
41. Ramamoorthy, S., Liu, W., Ma, Y., Yang-Feng, T., Ganapathy, V. and Leibach, F.: Proton/peptide cotransporter (PEPT2) from human kidney: functional characterization and chromosomal localization. Biochim. et. Biophys. Acta., 1240: 1-4 (1995).
42. Bahadurri, P., D'Souza, V., Pinsonneault, J., Sadee, W., Bao, S., Knoell, D. and Swaan, P.: Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium. Am. J. Resp. Cell Mol. Biol., 32: 319-325 (2005).
43. +/peptide cotransporter 2 causes a complete loss of transport function. Biochem. Biophys. Res. Commun., 316: 416-420 (2004).
44. +/dipeptide transporter PEPT2: analysis of haplotype functions. J. Pharmacol. Exp. Ther., 311: 1088-1096 (2004).